Prudential Financial Inc Exagen Inc. Transaction History
Prudential Financial Inc
- $70.8 Billion
- Q4 2024
A detailed history of Prudential Financial Inc transactions in Exagen Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 14,600 shares of XGN stock, worth $51,830. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,600
Previous 21,800
33.03%
Holding current value
$51,830
Previous $67,000
11.94%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.05MCall Options Held
1.1KPut Options Held
6.4K-
Rtw Investments, LP New York, NY1.51MShares$5.37 Million0.1% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$3.16 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$1.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.74 Million0.0% of portfolio
-
Morgan Stanley New York, NY484KShares$1.72 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $57.7M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...